Item 1.01 Entry into a Material Definitive Agreement

On February 22, 2023, Allied Healthcare Products, Inc. (the "Company") entered into an amendment (the "Amendment") to the Company's Loan and Security Agreement with Summit Financial Resources, LLC dated effective February 27, 2017 (as previously amended, the "Credit Agreement"). The Amendment is effective as of February 19, 2023 and amends the Credit Agreement as follows:

- The maturity date of the Credit Agreement was extended from February 20, 2023

to March 10, 2023.

- In consideration of the extension of the maturity date, the Company will pay an

extension fee to the lender of up to $42,500 as follows:

- A first installment of $8,000 paid upon signing of the amendment,

- A second installment of $14,500 payable on February 28, 2023, and

- A third installment of $20,000 payable on March 6, 2023, provided that if the

entire loan balance is paid down by March 3, 2023, this installment will be


   waived.



The foregoing summary of the amendment to the Credit Agreement is qualified in its entirety by reference to the Seventh Amendment to Loan and Security Agreement, a copy of which is filed herewith as Exhibit 99.1, and incorporated by reference herein.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


           Appointment of Certain Officers; Compensatory Arrangements of Certain
           Officers



(c) On February 22, 2023, the Board of Directors (the "Board") of the Company approved the appointment of the following officers:

- Akash Amin, age 31, was appointed as President and Chief Restructuring Officer

of the Company. Mr. Amin is a Director of the consulting firm MorrisAnderson

and has been employed since September 2018. Mr. Amin has held

interim-management positions as a CFO and Financial Advisor with

underperforming and bankrupt companies, and has optimized recoveries in

liquidations, receivership, and bankruptcy sales. Prior to joining

MorrisAnderson, Mr. Amin founded and was CEO of a management consulting firm

where he performed interim management services, buy and sell-side M&A financial

due diligence, strategic advisory, and post-acquisition operational

integration. Mr. Amin is a Certified Turnaround Professional (CTP).

- Mark Welch, age 57, was appointed as Vice-President and Assistant Chief

Restructuring Officer of the Company. Mr. Welch is a Principal of

MorrisAnderson. Mr. Welch is a CPA and is a Certified Turnaround Professional

(CTP). Mr. Welch has been employed with MorrisAnderson since January 1998. Mr.

Welch has held interim-management positions as a CFO, CRO, CEO and Financial

Advisor with underperforming and bankrupt companies, and has optimized

recoveries in liquidations, receivership, and bankruptcy sales. He has specific

expertise in environmental resolution, bankruptcy, forensic accounting, cost

reduction, asset recovery, restructuring plans and liquidation. He has also

testified in state and federal courts as an expert witness, prepared fraud

cases for the government and testified in bankruptcy court.

Neither Mr. Welch nor Mr. Amin will receive compensation for their services which are being provided as part of MorrisAnderson's restructuring services to the Company.

Each of Mr. Welch and Mr. Amin entered into indemnification agreements with the Company in the form filed as Exhibit 99.2 with this report on Form 8-K.

(e) On February 22, 2023, the Board adopted the following compensatory arrangements which will benefit the Company's Chief Financial Officer, Mr. Daniel C. Dunn:

The Board approved establishing a bonus pool for certain employees to provide incentives to remain employed with the Company and to maximize the value of the Company during the sale process that was previously approved by the Board and disclosed in a report on Form 8-K on January 31, 2023. The bonus pool will consist of 2.0% of the aggregate net proceeds, if any, resulting from any sales of the Company's assets or business. Participants in the bonus pool include key employees of the Company, including Mr. Dunn, who will have a 25.0% share of any amount in the bonus pool.

The Board also approved a retention bonus for Mr. Dunn in the amount of $35,000, subject to the condition that he does not voluntarily terminate his employment prior to the completion of the sale process.




Item 9.01     Financial Statements and Exhibits.



(a) Not applicable.



(b) Not applicable.



(c) Not applicable.



(d) Exhibits.



     Exhibit
     Number   Description

       99.1     Seventh Amendment to Loan and Security Agreement, dated effective
              as of February 19, 2023, by and between Allied Healthcare Products,
              Inc. and Summit Financial Resources, LLC
       99.2     Form of Indemnification Agreement between the Company and Mssrs.
              Welch and Amin, dated February 22, 2023
     104      Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses